Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Abstract: To suppress the leakage current in non-isolated rectifiers and reduce dc-link capacitance, this article proposes a novel single-phase common-ground rectifier with active power decoupling as ...